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Research Integrity
Scientific misconduct is a global problem, yet protocols for addressing it remain highly 
fragmented and uneven. A conference held last month in Lisbon aimed to encourage inter-
national efforts to promote research integrity and to prevent misconduct.High-profile cases of scientific mis-
conduct such as that of disgraced 
South Korean stem cell researcher 
Hwang Woo Suk have focused new 
attention on efforts to promote ethics 
in scientific research. At the time that 
Hwang published his now infamous 
research, South Korea lacked a formal 
policy for reporting scientific miscon-
duct, and the country had no policies 
in place to protect whistle blowers, 
says David Resnik, a bioethicist at 
the National Institute of Environmen-
tal Health Sciences in Durham, North 
Carolina. With science becoming an 
increasingly global pursuit, interna-
tional efforts to promote research 
integrity have gained momentum. 
“There’s no need to panic or say the 
sky is falling,” says Stefan Micha-
lowski, executive secretary at the 
Organization for Economic Coopera-
tion and Development (OECD) Global 
Science Forum in Paris, France. “But 
on a practical level, there’s a need to 
acknowledge the international dimen-
sion of the problem,” he says. The 
OECD’s Global Science Forum (GSF) 
comprises science policy officials 
from OECD countries who cooper-
ate at a government level on issues 
related to basic scientific research.
In an effort to encourage organiza-
tions and governments to consider 
implementing standard protocols for 
dealing with scientific misconduct, 
the GSF has prepared a draft report 
to provide a starting point for discus-
sions (http://www.oecd.org/sti/gsf). 
This report helped to catalyze organi-
zation of the first world conference on 
research integrity, which was held last 
month in Lisbon, Portugal (http://www.
esf.org/conferences/researchin-
tegrity). Co-organized by Nicholas 
Steneck at the Office of Research Integrity (ORI) of the U.S. Department 
of Health and Human Services in 
Rockville, Maryland and Tony Mayer 
of the European Science Founda-
tion (ESF) in Strasbourg, France, the 
conference brought together repre-
sentatives from 52 countries around 
the globe. “It was the first time we’ve 
gathered this many people together 
to discuss integrity in research,” says 
Mayer. “We had people from all walks 
of life in the research world—funders, 
universities, administrators and 
researchers.” Sponsored by ESF and 
ORI, the meeting was also supported 
by other prominent organizations 
including the International Council 
for Science (ICSU), the North Atlantic 
Treaty Organization (NATO), the Euro-
pean Molecular Biology Organization 
(EMBO), and the Committee on Publi-
cation Ethics (COPE).
Promoting Cross-Border  
Communication
The aim of the Lisbon meeting was 
not to produce a one-size-fits-all 
approach to solving issues of scientific 
misconduct—there was widespread 
agreement that solutions must be indi-
vidualized to the needs of each coun-
try and institution. Instead, the forum 
focused on jumpstarting cross-bor-
der discussion of the problem, says 
Mayer. “Science, as it’s practiced, is 
increasingly international and a lot of 
research structures are international, 
so if misconduct occurs, it can easily 
have international implications,” says 
Michalowski. “You need to get data 
and testimony and you need to get 
the facts and that may require getting 
those data from another country,” 
he says. Investigating misconduct 
can be difficult enough in one’s own 
country, but the problem becomes Cell 131even more challenging when the mis-
conduct involves researchers from 
another country. “Someone may have 
authority to investigate misconduct in 
their own country, but they have no 
such authority in other countries and 
they may not know who to talk to,” 
says Michalowski.
Meeting attendees all concurred on 
certain tenets, notes Mayer. “Every-
one can agree that fabrication, falsifi-
cation and plagiarism is wrong—that 
goes across cultures.” Likewise, 
there was wide agreement that those 
types of blatant scientific misconduct 
are rare, he says. But other forms of 
scientific misconduct are less easy to 
define, says Mayer. Pressure to pub-
lish and new technology have made 
it easier and perhaps more tempting 
for scientists to push the envelope a 
bit. “People sort of touching up their 
gels—things like that are a lot easier 
now than it used to be,” says Tim Hunt 
of Cancer Research UK, a speaker at 
the meeting. “There’s a bell curve with 
absolutely exemplary practice at one 
end and misconduct at the other and 
a big bell in the middle representing 
degrees of questionable practice,” 
says Mayer. “How do we address 
that? How do we ensure that people 
don’t slide down one side of the bell 
into the misconduct side?”
Ordinary People, Extraordinary 
Pressure
One proposed solution that is becom-
ing clear is the need to make changes 
to the research environment. “There 
are environmental factors that have 
a bearing on the way researchers 
behave, and these factors are defi-
nitely addressable and changeable,” 
says ORI’s Steneck. As an example, 
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cesses that pressure researchers 
to produce preliminary data, which 
he says can encourage researchers, 
especially those who depend on soft 
money, to lie or stretch the truth on 
grant applications. “Pressure is prob-
ably at an all-time high, and a lot of 
[misconduct] is probably people 
responding to this pressure,” says 
Resnik. Convicted fabricators often 
point to external pressures as the 
tipping point for their misdeeds. Eric 
Poehlman, who fabricated and falsi-
fied nearly a decade’s worth of work 
while at the University of Vermont, 
explained his behavior by saying 
he felt pressure to continue secur-
ing grants so that he could fund the 
numerous postdocs and graduate 
students who depended on his sup-
port to continue their careers.
While many, like Hunt, argue that 
a lab leader would have to be crazy 
to commit an ethical breach with so 
much at stake, Resnik believes that 
most cases involve ordinary people 
who gave in to extraordinary pres-
sure. “There’s evidence that if you 
make small compromises that leads 
to larger compromises,” says Ste-
neck. “Some people get caught in 
the timing of submitting things and 
they rush, and because they rush 
they take shortcuts that they might 
not otherwise take,” says Peggy 
Fischer, associate inspector general 
of the National Science Foundation 
in Arlington, Virginia. Institutions can 
relieve pressure or provide guidance 
on how to cope with it, but this won’t 
entirely eliminate the problem, says 
Fischer.
Effective solutions depend on lead-
ership, says Fischer. “An individual 
has to believe that that system has 
integrity. You have to have a culture 
where people feel the administration 
feels, breathes and walks integrity,” 
she says. “There’s no magic solu-
tion,” agrees Michalowski. “But you 
need strong leaders,” he emphasizes. 
Likewise, vigilant, meaningful educa-
tion must be built into the system. 
“You should have clear rules where 
people understand what’s expected 
and required,” says Fischer. Further-
more, people must be familiar with 
the rules and trust them to work.10 Cell 131, October 5, 2007 ©2007 ElseOne priority discussed in the 
OECD GSF draft report is the need to 
strengthen the first link in the chain of 
response to scientific misconduct. “If 
you’re a graduate student and you’re 
working late in the lab and going 
through the data and you’re begin-
ning to suspect that your esteemed 
research advisor is faking data, what 
do you do?” says Michalowski. Unless 
a person who detects misconduct 
feels safe blowing the whistle, the 
problem may go unreported.
Dealing with Misconduct
The Lisbon meeting did not attempt to 
find an ideal method for handling mis-
conduct but instead provided a forum 
for delegates to exchange ideas for 
how to deal with it. Some countries 
still lack a formalized, documented, 
publicized process for dealing with 
misconduct. “They deal with this 
problem in an ad-hoc basis and when 
an allegation is made, maybe it gets 
into the press, then people scramble 
and they put together a committee 
composed of trusted prestigious 
people, and they deliberate and make 
some sort of decision,” says Micha-
lowski. Other countries have formal 
processes for receiving and handling 
allegations. “There really is a spec-
trum of systems, from improvisation 
to a quasi-legal system,” he says.
But even if a formal process for 
dealing with misconduct exists in 
the country or institution of the sci-
entist suspected of misdeeds, that 
scientist’s culture may not consider 
the behavior unethical. For instance, 
some Asian countries don’t view indi-
viduality and individual rights and 
responsibilities in the same way that 
Western countries do, and this differ-
ence of values can create problems 
regarding authorship and plagiarism, 
says Resnik. “Some people may think 
it’s a common piece of research and 
it doesn’t matter so much who takes 
credit for that.” Likewise, “some 
countries don’t have the same regard 
for human rights as we do and while 
we have international codes and 
standards for human research it’s not 
always clear how well other countries 
are adhering,” says Resnik. “Politics 
is always a potential factor here.”vier Inc.Steneck considers culture gaps a 
surmountable obstacle. “There are 
cultural differences that are going to 
make the process difficult but every 
country needs to think about what 
their cultural differences are, and 
whether they can be justified,” he 
says. “You will hear, for example, that 
we have different attitudes toward 
authorship in [the US]—we tend to 
give senior people more credit,” he 
says. “But you wouldn’t say, well in 
our country, we just don’t believe 
in double blind experiments. Does 
authorship fall into the same realm? 
It is misleading to put someone on 
a paper who really didn’t contribute 
anything, and I don’t think that cul-
tural differences should stand in the 
way of this,” Steneck says.
Perhaps even more challeng-
ing than cultural differences is a 
shared tendency to view science 
as a noble pursuit immune to fraud. 
Many countries and organizations 
still subscribe to the notion that sci-
ence is a brotherhood of gentlemen 
who can’t lie, says Michalowski. 
“This idea goes back to when sci-
ence was a much smaller institution 
and it has survived long after sci-
ence changed,” says Michalowski. 
“We don’t believe that science is a 
special case—in any profession you 
can have some dishonesty.”
Resnik says that much of the mis-
conduct that turns up in science is 
simply spill over from problems fac-
ing society as a whole. “Surveys con-
sistently show that the incidence of 
cheating in high school and college 
is very high, well over 50 percent and 
it’s unreasonable to expect that these 
people who were cheating in college 
will never cheat again,” says Resnik. 
“It’s not surprising that you find fraud 
in science—scientists are people 
too–but we tend to hold scientists up 
on a pedestal,” he says.
Even with the apparent rise in 
high-profile cases of research mis-
conduct, many in the scientific 
community have been reluctant 
to discuss the problem publicly. “I 
honestly think it’s better to just qui-
etly deal with a person than to bring 
in the SWAT team and start some 
huge public investigation,” says 
Hunt. A heavy-handed approach, 
he says, reinforces the idea in the 
public’s mind that scientists are 
dishonest. “Every time the whistle 
is blown, the public says scien-
tists can’t be trusted,” says Hunt. 
Michalowski disagrees with this 
argument. “People may worry that 
even if your motives are pure, you 
risk doing harm to the system by 
exposing fraud, but when the public 
learns that data were faked in a drug 
trial, the damage is even greater,” 
he says.
Those who handle scientific mis-
conduct report a rise in the number 
of cases in recent years, but this may 
be a sign of better surveillance, rather 
than an increase in actual incidence. 
“Our numbers have gone up signifi-
cantly in the past few years, but we 
don’t know what the baseline is,” 
says Fischer. Misconduct can easily 
slip under the radar if whistle blow-
ers don’t feel safe reporting it, she 
says. “The system has to have a way 
to receive allegations in which the 
person submitting the allegation feels 
comfortable doing that, so that the 
fears inherent in reporting–like losing 
funding or retaliation are reduced to 
the lowest level possible,” she says. 
Fischer believes that misconduct is 
underreported but says that no good comprehensive studies of scientific 
misconduct exist and without them, 
it’s difficult to quantify the number of 
actual cases.
International and National 
Solutions
The Lisbon meeting and GSF draft 
report provide first steps toward inter-
national cooperation on maintain-
ing scientific integrity and preventing 
research misconduct. However, indi-
vidual countries are also moving for-
ward with their own policies. For exam-
ple, Germany has implemented an 
innovative ombudsman system meant 
to address problems before they blow 
up. The system consists of ombuds-
men at both the national and institu-
tional level, says Ulrike Beisiegel, chair 
of the DFG Ombudsman. The national 
ombudsman is an independent, neutral 
person trained to mediate and navigate 
ethical challenges. “Every researcher 
in Germany can contact us if he has 
information about someone who might 
have done something wrong,” says 
Beisiegel. The ombudsman can advise 
whistle blowers, conduct preliminary 
investigations, and try to mediate the 
problem and settle it in an amicable 
way, if possible. So far, the national 
ombudsman office has handled about 
60 to 70 cases per year, says Beisiegel. Cell 131The system has safeguards in place to 
protect both the whistle blower and the 
alleged perpetrator of the misconduct. 
“Our goal is to go in early,” says Beisie-
gel. “Most of the people come to us 
too late. If it’s an authorship issue, it’s 
after the paper is published. So we’re 
setting up a curriculum for students so 
they know how they should behave and 
what they should do,” says Beisiegel.
The Lisbon conference has encour-
aged decision-makers to think about 
the big issues facing them. “The con-
versations have started, and now 
we can continue these conversa-
tions—that’s what we’re hoping will 
come out of the world conference. 
It’s a first step,” says Steneck. Dur-
ing the meeting, some suggested 
that the logical next step should be 
a series of regional meetings, for 
instance a group of Asian nations 
coming together to discuss scien-
tific integrity, says Mayer. “There is 
a feeling we need to come together 
again, but where and when is still up 
for debate.”
“I’m optimistic,” Steneck says. 
“Five or six years ago there was 
very little global interest and that’s 
changed. I think there are significant 
components of the research commu-
nity who realize we do need to take 
these issues seriously.”
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